CDK1 and ovarian cancer: More intriguingly, the stabilization of pVHL by targeting CDK1 could also be a common regulatory mechanism in various types of cancer cells harboring wild-type VHL, including TNBC, pancreatic cancer, colorectal cancer and ovarian cancer (Fig. 6K, L).